FDA/CDC

FDA recalls kratom products for salmonella contamination


 


Kratom, a plant that commonly grows in South East Asian countries like Thailand, Malaysia, Indonesia, and Papua New Guinea, has recently been used to produce food supplements and marketed as an alternative to addictive pain medication like opioids, as well as used to help treat opioid withdrawal symptoms.

Use of the food supplement has fired debate among physicians, patients, and public officials as all sides continue to determine its efficacy and how, or whether, it should be given a drug classification.

Pages

Recommended Reading

Serotonin syndrome warnings magnify its rare probability
MDedge Psychiatry
Serotonin syndrome risk with triptans and antidepressants ‘very low’
MDedge Psychiatry
Opioid deaths in the ED increase nationally
MDedge Psychiatry
Nonopioid analgesics have no major disadvantages vs. opioids for chronic pain
MDedge Psychiatry
Opioid prescriptions got shorter in 2017
MDedge Psychiatry
The case for being open-minded about medical marijuana
MDedge Psychiatry
MDedge Daily News: Why the barber’s chair can help hypertension
MDedge Psychiatry
Is kratom the answer to the opioid crisis?
MDedge Psychiatry
FDA advisors recommend lofexidine for opioid withdrawal
MDedge Psychiatry
How precision psychiatry helped my patient; Ketamine: The next ‘opioid crisis’?
MDedge Psychiatry